ENTX - Entera Bio Ltd Net earnings per share (EPS TTM)
Entera Bio Ltd. (ENTX) bases its generic defense on chemical patents for oral protein delivery. The TTM net income per share reflects current valuation trends, with the metric currently at -0.39. Strict FDA oversight and an IT platform for converting injections into tablets create high barriers to entry. The development is further complemented by the implementation of robotic modules to automate laboratory testing.
Analytical breakdowns and data insights for company Entera Bio Ltd (ENTX)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
- net income and valuation multiples indicators:
ENTX - Final Profit|Projected Future Earnings Entera Bio Ltd.|ENTX - P/E Multiple|Projected Price to Earnings Entera Bio Corp|ENTX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Entera Bio Ltd.|ENTX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Entera Bio|ENTX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months enterabio.com|ENTX - Earnings per share growth rate in current year|Expected earnings per share growth for next year Entera Bio Ltd.
Fundamental valuation:enterabio.com - ENTX
Investors are seeking fundamental drivers of stability by analyzing the real returns of the business. This metric is calculated by dividing the total annual net income by the total number of shares outstanding. The 12-month net income per share trend on this chart demonstrates the efficiency of capital management. For Entera Bio Ltd. (ENTX), this indicator reflects the financial success of commercializing oral drug delivery systems. Growth in this metric would confirm the profitability of implementing tablet forms of hormonal drugs.
Who Entera Bio Ltd. competes with
HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LQDA (Liquidia)|Galapagos N.V. (GLPG) - Net earnings per one share for the last twelve months|ANIP - Earnings per share for the last twelve months|MNKD (Afrezza) - Earnings per share for the last 12 months|AMPH (Amphastar Pharmaceuticals) - Net earnings per share for the last 12 months|PCRX: Earnings per share for the last four quarters|SPRY (ARS Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Theravance Biopharma Inc TBPH|Earnings per share for the last twelve months Aquestive Pharma (AQST)|SCPH (scpharmaceuticals.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|Net earnings per share (EPS TTM) tonixpharma.com TNXP|SXTC: Net earnings per share for the last 12 months|Earnings per share for the trailing year EPRX (Eupraxia Pharmaceuticals)|BHST: Net earnings per share (EPS TTM)|EXOZ (Invizyne) - Earnings per share for the last twelve months|ORMP (Oramed) - Net earnings per share (EPS TTM)|ipatherapeutics.com (HYFT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months ABVC BioPharma, Inc. (ABVC)|CPIX - Net earnings per one share for the last twelve months|Quantum BioPharma Limited - Net earnings per share for the last 12 months|Earnings per share for the trailing year FGEN|TELO - Earnings per share for the last twelve months|RANI: Earnings per share for the last twelve months|SNYR (synergychc.com) - Net earnings per share for the last 12 months|RLYB: Earnings per share for the last four quarters|LEXX (Lexaria Bioscience Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PULM (Pulmatrix Corporation)|Net earnings per share for the last 12 months PTHL (Pheton Holdings Ltd)|Net earnings per share for the last four quarters aptorumgroup.com|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics)|Impact BioMedical, Inc. (IBO) - Net earnings per one share for the last twelve months|TNFA - Earnings per share for the last twelve months|YCBD (cbdMD, Inc.) - Earnings per share for the last 12 months|PRFX (PainReform Ltd.) - Net earnings per share for the last 12 months|CYTO: Earnings per share for the last four quarters|Net earnings per share for the last 12 months LIPO|Earnings per share for the last 12 months OPTN (OptiNose Inc)|Earnings per share for the last twelve months Pieris (PIRS)|PROC: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PTPI (Petros Pharmaceuticals)|Earnings per share for the trailing year QLI|ACELYRIN - Net earnings per share (EPS TTM)|TFFP - Net earnings per share (EPS TTM)
